HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasushi Tomita Selected Research

Oculocutaneous Albinism (Albinism, Yellow Mutant)

10/2005High frequency of Hermansky-Pudlak syndrome type 1 (HPS1) among Japanese albinism patients and functional analysis of HPS1 mutant protein.
7/2005Ultrastructural features of trafficking defects are pronounced in melanocytic nevus in Hermansky-Pudlak syndrome type 1.
11/2004Genetics of pigmentary disorders.
5/2003Six novel P gene mutations and oculocutaneous albinism type 2 frequency in Japanese albino patients.
2/2002A novel mutation of the tyrosinase gene causing oculocutaneous albinism type 1 (OCA1).
1/2002Polymorphic sequences of the tyrosinase gene: allele analysis on 16 OCA1 patients in Japan indicate that three polymorphic sequences in the tyrosinase gene promoter could be powerful markers for indirect gene diagnosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasushi Tomita Research Topics

Disease

7Neoplasms (Cancer)
01/2019 - 12/2008
6Oculocutaneous Albinism (Albinism, Yellow Mutant)
10/2005 - 01/2002
5Melanoma (Melanoma, Malignant)
02/2011 - 12/2008
3Atopic Dermatitis (Atopic Eczema)
09/2011 - 11/2004
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2011 - 10/2004
3Psoriasis (Pustulosis Palmaris et Plantaris)
09/2011 - 09/2009
3Oculocutaneous albinism type 1
09/2005 - 02/2002
3Erythema
10/2004 - 02/2002
2Hemangioma (Angioma)
03/2015 - 12/2013
2Inflammation (Inflammations)
01/2010 - 02/2002
2Type IV Oculocutaneous Albinism
08/2009 - 10/2006
2Dyschromatosis symmetrica hereditaria 1
10/2008 - 09/2003
2Autoimmune Diseases (Autoimmune Disease)
06/2006 - 11/2004
2Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome)
10/2005 - 07/2005
2Hemorrhage
10/2005 - 07/2005
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2005 - 10/2004
1Cardiac Sudden Death (Sudden Cardiac Arrest)
12/2020
1Spasm (Spasms)
12/2020
1Frailty
01/2019
1Atrial Fibrillation
01/2019
1Capillary Hemangioma
03/2015
1Pigmentation Disorders (Ito Syndrome)
09/2013
1Dowling-Degos Disease
09/2013
1Psychomotor Disorders
05/2012
1Chest Pain (Chest Pains)
04/2012
1Thrombosis (Thrombus)
04/2012
1Myocardial Infarction
04/2012
1Heart Failure
04/2012
1Extranodal Extension
02/2012
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2011
1Xeroderma Pigmentosum (Kaposi's Disease)
10/2010
1Myositis (Idiopathic Inflammatory Myopathies)
09/2010
1Dermatomyositis (Dermatopolymyositis)
09/2010
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2010
1Asthma (Bronchial Asthma)
01/2010
1Wounds and Injuries (Trauma)
08/2009
1Mixed Connective Tissue Disease (MCTD)
05/2009
1Thrombotic Thrombocytopenic Purpura
05/2009
1Systemic Scleroderma (Systemic Sclerosis)
04/2009
1Necrosis
04/2009
1Ulcer
04/2009

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
12/2010 - 05/2003
8AutoantibodiesIBA
09/2011 - 10/2004
5lens epithelium-derived growth factorIBA
09/2011 - 11/2004
4Melanins (Melanin)IBA
08/2009 - 02/2002
4Monophenol Monooxygenase (Tyrosinase)IBA
09/2005 - 01/2002
3AntibodiesIBA
09/2010 - 10/2004
2Propranolol (Inderal)FDA LinkGeneric
03/2015 - 12/2013
2Cyclosporine (Ciclosporin)FDA LinkGeneric
09/2011 - 08/2004
2Endoplasmic Reticulum Chaperone BiPIBA
09/2011 - 09/2009
2AutoantigensIBA
09/2011 - 01/2007
2Immunoglobulin G (IgG)IBA
09/2011 - 11/2004
2AntigensIBA
04/2009 - 03/2009
2Messenger RNA (mRNA)IBA
03/2009 - 02/2005
2RNA (Ribonucleic Acid)IBA
10/2008 - 09/2003
2Adenosine DeaminaseIBA
10/2008 - 09/2003
2Ointments (Pastes)IBA
05/2006 - 09/2002
2CeroidIBA
10/2005 - 07/2005
2Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2005 - 02/2004
2DNA (Deoxyribonucleic Acid)IBA
01/2005 - 10/2004
1Vasodilator Agents (Vasodilators)IBA
12/2020
1Serum AlbuminIBA
01/2019
1AnticoagulantsIBA
01/2019
1Retinaldehyde (Retinal)IBA
03/2015
1Therapeutic UsesIBA
12/2013
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
12/2013
1Dichlorodiphenyldichloroethane (DDD)IBA
09/2013
1Olopatadine Hydrochloride (Patanol)FDA Link
05/2012
1fexofenadine (Allegra)FDA LinkGeneric
05/2012
1Promethazine (Promet)FDA LinkGeneric
05/2012
1Sirolimus (Rapamycin)FDA Link
04/2012
1Capsules (Microcapsules)IBA
02/2012
1Immunoglobulin E (IgE)IBA
09/2011
1Immunologic Factors (Immunomodulators)IBA
09/2011
1cyclosporin DIBA
09/2011
1Vincristine (Oncovin)FDA LinkGeneric
02/2011
1NimustineIBA
02/2011
1Alkylating AgentsIBA
02/2011
1Dacarbazine (DIC)FDA LinkGeneric
02/2011
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2010
1ErbB Receptors (EGF Receptor)IBA
08/2010
1Coloring Agents (Dyes)IBA
07/2010
1Bronchodilator Agents (Bronchodilators)IBA
01/2010
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2010
1Hyaluronic Acid (Hyaluronan)IBA
08/2009
1LigandsIBA
08/2009
1Interleukin-6 (Interleukin 6)IBA
08/2009
1Transforming Growth Factor beta (TGF-beta)IBA
08/2009
1Toll-Like Receptors (Toll-Like Receptor)IBA
08/2009
1thiamine triphosphorate (TTP)IBA
05/2009
1Peptide Hydrolases (Proteases)FDA Link
04/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2009
1Daunorubicin (Cerubidine)FDA LinkGeneric
03/2009
1MART-1 AntigenIBA
03/2009

Therapy/Procedure

6Therapeutics
12/2020 - 08/2004
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
12/2020
1Stents
04/2012
1Critical Care (Surgical Intensive Care)
04/2012
1Drug Therapy (Chemotherapy)
02/2011
1Occlusive Dressings (Occlusive Dressing)
04/2009